November Editors’ Picks from AACR Journals
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55...
The inaugural Cancer Disparities Progress Report, published today by the American Association for Cancer Research (AACR), highlights the urgent need...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
Each month, the editors of the nine AACR journals select one article from each issue to highlight. The featured articles for September described the preclinical evaluation...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
For the month of June, the editors of the nine AACR journals highlighted results from two clinical trials, preclinical data on KRAS inhibitors...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Researchers are exploring new options for kidney cancer treatments.
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
The summer issue of Cancer Today is out and features stories on the challenge of having both cancer and...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
For the month of August, the editors of the nine AACR journals have chosen to highlight results from two clinical...
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
World Cancer Day is February 4, 2023. This annual initiative by the Union for International Cancer Control (UICC) aims...
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
Guest Post by Kent Osborne, MD Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine;...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
As part of ongoing efforts to increase dialogue between cancer patients, survivors, physicians, and researchers, Cancer Today hosts an...
As we celebrate National Cancer Survivor Month, we are aware how the term survivor can take on many meanings...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
This was another spectacular year for the AACR Annual Meeting with its record-breaking attendance of more than 22,500. From...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
The COVID-19 pandemic continues to impact the United States and other parts of the world. To date, 13 million cases have been...
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...